AstraZeneca's blood pressure drug wins U.S. approval

Anglo-Swedish drugmaker AstraZeneca said on Monday its hypertension pill baxdrostat had been approved in the United States, offering a new treatment option for millions of patients with uncontrolled high blood pressure despite ​existing medicines.